Remarkably, the brain of MPS-IIIA mice treated with IDSspSGSH-IRES-SUMF1 showed a strong reduction of GFAP signal as compared with control affected mice, indicating a striking reduction of inflammatory processes (Figure 3D). The gene discussed is GFAP; the disease is mucopolysaccharidosis.